Related references
Note: Only part of the references are listed.Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G. House et al.
CLINICAL CANCER RESEARCH (2020)
Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis
Qiuping Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Antitumor effects of immunity-enhancing traditional Chinese medicine
Yeshu Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
Qiyao Yang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Baicalein inhibits non-small-cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironment
Xiaolong Zhang et al.
CANCER SCIENCE (2020)
The Biological Activities and Therapeutic Potentials of Baicalein Extracted from Oroxylum indicum: A Systematic Review
Nik Nur Hakimah Nik Salleh et al.
MOLECULES (2020)
Drp1-mediated mitochondrial fission contributes to baicalein-induced apoptosis and autophagy in lung cancer via activation of AMPK signaling pathway
Xiaohong Deng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Baicalein Exerts Anticancer Effect in Nasopharyngeal Carcinoma In Vitro and In Vivo
Jiandong Guo et al.
ONCOLOGY RESEARCH (2019)
Immunotherapeutic effects of intratumoral nanoplexed poly I:C
M. Angela Aznar et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide
Chanju Lee et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells
Mengyun Ke et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Harnessing tumor-associated macrophages as aids for cancer immunotherapy
Xiaolei Li et al.
MOLECULAR CANCER (2019)
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment
Elisa Peranzoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments
Jong W. Yu et al.
PLOS ONE (2018)
Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro
Wanjun Yan et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy
Sean P. Arlauckas et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma
Beibei Bie et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau et al.
NATURE (2016)
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda et al.
NATURE (2016)
Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
Nagendra Sastry Yarla et al.
SEMINARS IN CANCER BIOLOGY (2016)
Iciartin, a novel FASN inhibitor, exerts anti-melanoma activities through IGF-1R/STAT3 signaling
Jinfeng Wu et al.
ONCOTARGET (2016)
The Fascinating Effects of Baicalein on Cancer: A Review
Hui Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function
Eoin N. McNamee et al.
IMMUNOLOGIC RESEARCH (2013)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
Share Paper
